Allogeneic Transplant Outcomes in Patients Aged ≥70 Vs <70 with Fludarabine/Melphalan Conditioning and Post-Transplant Cyclophosphamide
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
Allogeneic Transplant Outcomes in Patients Aged ≥70 Vs <70 with Fludarabine/Melphalan Conditioning and Post-Transplant Cyclophosphamide | Researchclopedia